Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;11(2):236-51.
doi: 10.1038/nprot.2015.135. Epub 2016 Jan 7.

Preparation of pyrenyl-based multifunctional nanocomposites for biomedical applications

Affiliations

Preparation of pyrenyl-based multifunctional nanocomposites for biomedical applications

Eun-Kyung Lim et al. Nat Protoc. 2016 Feb.

Abstract

Nanocomposites are widely used to obtain an accurate diagnosis of, and to provide effective therapy for, a number of diseases, because they can be easily formulated by introducing therapeutic agents (e.g., drugs and genes) and imaging agents (e.g., magnetic nanocrystals). Furthermore, nanocomposites can be developed as all-in-one systems, which enable cancer diagnosis and therapy, as well as the simultaneous monitoring of drug behavior. In this protocol, we describe the synthesis of four pyrenyl-based polymers (pyrenyl polyethylene glycol (Py-PEG), pyrenyl dextran (Py-DEX), pyrenyl hyaluronan (Py-HA) and pyrenyl-conjugated heterofunctional PEG (pyrenyl PEG)) and their subsequent use in the preparation of multifunctional nanocomposites for different applications including multimodal imaging, targeted cancer detection and pH-sensitive drug delivery. Notably, these nanocomposites can be used to simultaneously perform multiple tasks--for example, delivering magnetic particles for early cancer detection by MRI, efficient cataloging of patient groups for personalized therapy and real-time monitoring of disease progress. Starting from the synthesis of pyrenyl-based polymers, this protocol can be completed in ∼15 d.

PubMed Disclaimer

References

    1. Adv Drug Deliv Rev. 2010 Aug 30;62(11):1064-79 - PubMed
    1. Adv Drug Deliv Rev. 2010 Mar 8;62(3):316-28 - PubMed
    1. Biomacromolecules. 2011 May 9;12(5):1460-7 - PubMed
    1. Adv Mater. 2011 Jun 3;23(21):2436-42 - PubMed
    1. Langmuir. 2010 Nov 16;26(22):17520-7 - PubMed

Publication types

LinkOut - more resources